RHK Stock Overview
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €11.40 |
52 Week High | €13.60 |
52 Week Low | €9.65 |
Beta | -0.014 |
1 Month Change | 16.92% |
3 Month Change | 10.68% |
1 Year Change | -12.31% |
3 Year Change | -28.39% |
5 Year Change | -55.78% |
Change since IPO | -59.99% |
Recent News & Updates
Recent updates
Shareholder Returns
RHK | AT Healthcare | AT Market | |
---|---|---|---|
7D | -1.7% | -1.1% | 1.6% |
1Y | -12.3% | -2.0% | 8.0% |
Return vs Industry: RHK underperformed the Austrian Healthcare industry which returned -2% over the past year.
Return vs Market: RHK underperformed the Austrian Market which returned 8% over the past year.
Price Volatility
RHK volatility | |
---|---|
RHK Average Weekly Movement | 5.6% |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 3.2% |
10% most volatile stocks in AT Market | 5.0% |
10% least volatile stocks in AT Market | 1.6% |
Stable Share Price: RHK has not had significant price volatility in the past 3 months.
Volatility Over Time: RHK's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 18,158 | Tobias Kaltenbach | https://www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
RHK fundamental statistics | |
---|---|
Market cap | €749.71m |
Earnings (TTM) | €31.92m |
Revenue (TTM) | €1.71b |
23.5x
P/E Ratio0.4x
P/S RatioIs RHK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RHK income statement (TTM) | |
---|---|
Revenue | €1.71b |
Cost of Revenue | €1.50b |
Gross Profit | €202.27m |
Other Expenses | €170.35m |
Earnings | €31.92m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | 0.48 |
Gross Margin | 11.85% |
Net Profit Margin | 1.87% |
Debt/Equity Ratio | 11.9% |
How did RHK perform over the long term?
See historical performance and comparison